Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor

Fibroblast growth factor receptor (FGFR) is associated with proliferation, migration, and angiogenesis of carcinomas, and FGFR signaling inhibitors are considered a key drug for the treatment of solid tumors with FGFR overexpression. Amplification of FGFR2 is reportedly identified in 3%‐10% of gastr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuroda, Kenji, Yashiro, Masakazu, Miki, Yuichiro, Sera, Tomohiro, Yamamoto, Yurie, Sugimoto, Atsushi, Nishimura, Sadaaki, Kushiyama, Shuhei, Togano, Shingo, Okuno, Tomohisa, Ohira, Masaichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734156/
https://www.ncbi.nlm.nih.gov/pubmed/32946655
http://dx.doi.org/10.1111/cas.14654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734156/
https://www.ncbi.nlm.nih.gov/pubmed/32946655
http://dx.doi.org/10.1111/cas.14654

Ejemplares similares